Singapore's Paragon REIT said it received a buyout offer from its major shareholder, Cuscaden Peak, and parties valuing the real estate firm at S$2.78 billion ($2.05 billion). Merck KGaA, the German ...
Artificial intelligence could be used to prescribe medications to patients — if a new bill makes its way through Congress ...
Roche's sale of InterMune and Esbriet in the US comes as Boehringer revealed its own follow-up play in the IPF, category, ...
Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and ...
Following an initial report from Reuters, Merck KGaA confirmed that it is in talks with SpringWorks for a potential ...
Indian transportation fuel demand is expected to rise in the range of 6%-8% in fiscal year 2026, underpinned by rising ...
CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...
Merck said in a brief statement that discussions are "advanced" but noted that "critical conditions have yet to be met" ...
As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
Reacting to press reports, Germany’s Merck KGaA has confirmed it is in advanced discussions with SpringWorks Therapeutics with the aim of acquiring the US biotechnology company.
Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...
Die Merck KGaA befindet sich in fortgeschrittenen Verhandlungen zum Kauf des amerikanischen Krebsspezialisten SpringWorks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback